Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Oncology Letters|May 23, 2017
Synthesis, characterization and anticancer activities of transition metal complexes with a nicotinohydrazone ligandShanshan Shen, Hong Chen, Taofeng Zhu, et al.Frontiers in Cell and Developmental Biology|February 21, 2022
PPARγ/SOD2 Protects Against Mitochondrial ROS-Dependent Apoptosis via Inhibiting ATG4D-Mediated Mitophagy to Promote Pancreatic Cancer ProliferationShuang Nie, Zhao Shi, Mengyue Shi, et al.Journal of Gastroenterology and Hepatology|May 25, 2022
Diagnostic value of endoscopic ultrasound-guided fine needle aspiration with rapid on-site evaluation performed by endoscopists in solid pancreatic lesions: A prospective, randomized controlled trialSong Zhang, Muhan Ni, Pin Wang, et al.International Journal of Medical Informatics|October 13, 2024
Pathologist-level diagnosis of ulcerative colitis inflammatory activity level using an automated histological grading methodChengfei Cai, Qianyun Shi, Jun Li, et al.Gastrointestinal Endoscopy|July 3, 2020
EUS-guided portal pressure gradient measurement in patients with acute or subacute portal hypertensionWei Zhang, Chunyan Peng, Song Zhang, et al.American Journal of Cancer Research|April 6, 2019
Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinomaXiwei Ding, Yiyang Zhang, Tianlu Huang, et al.American Journal of Cancer Research|December 7, 2023
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinomaXiwei Ding, Yiyang Zhang, Tianlu Huang, et al.Hepatology International|January 28, 2021
Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shuntJiangqiang Xiao, Jingjing Tu, Han Zhang, et al.Frontiers in Oncology|July 3, 2020
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose MetabolismShuang Nie, Xuetian Qian, Mengyue Shi, et al.Scientific Reports|December 28, 2025
The prevalence and predictors of non-alcoholic fatty liver disease in Chinese patients with inflammatory bowel disease: a multicenter retrospective studyYonghua Shen, Feng Liang, Qingqing Li, et al.Pageof 9